Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic
Share Article
Targeted Intraoperative Radiotherapy or TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 6-week radiotherapy, significantly reducing COVID-19 risk to patients. Mercy Medical Center in Baltimore, MD, is offering TARGIT-IORT using the Intrabeam® System. Mercy was the first hospital in Maryland to acquire the INTRABEAM® Radiotherapy System in 2012. BALTIMORE (PRWEB) December 16, 2020 SINGLE-DOSE RADIATION THERAPY CAN COUNTERACT SERIOUS BREAST CANCER TREATMENT COMPLIANCE ISSUES DURING PANDEMIC
TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 6-week radiotherapy, significantly reducing COVID-19 risk to patients
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronaviru
E-Mail
TAMPA, Fla. Prostate cancer is one of the most common cancers among men in the United States. One in nine men will be diagnosed during his lifetime. When diagnosed, a patient s disease is graded from 1 to 5 based on how aggressive it is, with 5 being the most aggressive. Those with grades 4/5 disease are at the highest risk of poor outcomes or death from the disease; however, there are no immunologic or genomic indicators that can help physicians determine the best course of treatment for this group of patients.
Moffitt Cancer Center researchers, led by Kosj Yamoah, M.D., Ph.D., associate member and director of cancer disparities research in the departments of Radiation Oncology and Cancer Epidemiology, are hoping to change that. The team conducted studies to determine if genomic heterogeneity in tumors from grade 4/5 prostate cancer patients can be exploited to identify patient subsets that are at higher risk for lethal outcomes and that may benefit from targeted treatm
Single-dose radiation therapy may lessen, eliminate unsafe additional outside trips during the pandemic
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.
However, physicians at Mercy Medical Center are countering this trend with a procedure called Targeted Intraoperative Radiotherapy, or TARGIT-IORT using the Intrabeam
® System from ZEISS. Mercy was the first hospital in Maryland to acquire the INTRABEAM
® Radiotherapy System in 2012, and remains the only hospital in the state to offer patients the INTRABEAM system.
Hoag Brings Groundbreaking Cancer Treatment Technology to Orange County
The first MRI-guided radiation therapy system provides real-time view of tumors during radiation treatment
December 15, 2020 Hoag Memorial Hospital Presbyterian became the only hospital in Orange County, and one of the first in the nation, to provide oncologists with the technology to pinpoint tumors during radiation treatment – even in some of the most difficult-to-target areas in the body, including the pancreas, lungs and other soft tissue tumors. Hoag will be utilizing this new treatment as part of its recent opening of a unique cell therapy trial for pancreatic tumors.
The real-time images provided by the ViewRay MRIdian help the dedicated radiation oncology team at Hoag Family Cancer Institute keep a radiation beam directly on target throughout every treatment, allowing for a degree of precision and monitoring capabilities that were not previously possible.
Researchers identify genomic and immune indicators that predict lethal outcomes in prostate cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.